As for the AhR bioactivity data, further adjustment for a history of myocardial infarction, stroke, heart failure, diabetes and medication for hypertension, diabetes or hyperlipidaemia only had a marginal effect on the correlations between ATP concentration and TEQ or individual POPs. The gene discussed is AHR; the disease is hyperlipidemia.